CCL5 and pulmonary arterial hypertension: CCL5 is one of the members of the CC-chemokine family, having a complex impact on immune cells such as monocytes, T lymphocytes, and NK cells [54]; it is strongly expressed on vascular endothelial cells and exerts vasoconstriction and remodeling effects on the lung tissue of patients with PAH [52,55].